RxDoctor Payments DataLook up a doctor →

Eli Saleeby, MD

MOHS-Micrographic Surgery · Coral Springs, FLNPI 1356392294

Payments from drug & device makers

$864,365in general payments, 2019–2025

Across 245 payments — averaging $3528.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$401K
  • Sanofi US Services Inc.$117K
  • Incyte Corporation$84K
  • Amgen$83K
  • E.r. Squibb & Sons, L.L.C.$73K
  • Eli Lilly$64K
  • plus $42K from 25 others
$1,372in research payments, 2019–2025

Across 9 payments — averaging $152.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$1K
  • Eli Lilly$105

What the payments were for

  • Consulting fees$2,00022%
  • Speaking & faculty fees$801%
  • Food & beverage$6,91576%
  • Education$831%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$864,365 in reported general payments places this provider in the 95th percentile of 141 mohs-micrographic surgery providers in Florida.

See all mohs-micrographic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$507,649
Medicare patients
375
Services billed
1,864

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin303$2,380
Cephalexin202$1,016
Gentamicin Sulfate16$655
Doxycycline Hyclate54$467
Triamcinolone Acetonide31$344
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen40$193
Ketoconazole11$148
Azithromycin11$88
Hydroxyzine Hcl12$63

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Coral Springs

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →